Supply of DTwP containing vaccines through UNICEF for the period of 2023-2027

The United Nations Children’s Fund (UNICEF) promotes the rights and wellbeing of every child in everything we do. Together with our partners, we work in 190 countries and territories to translate that commitment into practical action, focusing special effort on reaching the most vulnerable and excluded children, to the benefit of all children, everywhere. The fundamental mission of UNICEF is to promote the rights of every child, everywhere, in everything the organization does — in programs, in advocacy and in operations. The equity strategy, emphasizing the most disadvantaged and excluded children and families, translates this commitment to children’s rights into action. For UNICEF, equity means that all children have an opportunity to survive, develop and reach their full potential, without discrimination, bias or favoritism. To the degree that any child has an unequal chance in life — in its social, political, economic, civic and cultural dimensions — her or his rights are violated. There is growing evidence that investing in the health, education and protection of a society’s most disadvantaged citizens — addressing inequity — not only will give all children the opportunity to fulfil their potential but also will lead to sustained growth and stability of countries. This is why the focus on equity is so vital. It accelerates progress towards realizing the human rights of all children, which is the universal mandate of UNICEF, as outlined by the Convention on the Rights of the Child, while also supporting the equitable development of nations.

UNICEF vaccine procurement is guided by the principle of vaccine security: the sustained, uninterrupted supply of affordable vaccines of assured quality.

The purpose of this Request for Proposal (RFP) is to establish long-term arrangements for uninterrupted supply of DTwP containing vaccines through UNICEF for the period of 2023-2027.

The following vaccines, referred to as “DTwP containing vaccines” are included in this RFP:

• DTwP Vaccine (10-dose vial presentation)
• DTwP-HepB-Hib vaccine (1 and 10-dose vial presentation)
• DTwP-HepB-Hib-IPV (Hexavalent) vaccine

Vaccines included in this tender are to be supplied to Gavi eligible countries as well as other countries, receiving DTwP containing vaccines in these combinations, through UNICEF.

As a result of this RFP, UNICEF will work with selected manufacturers to establish supply arrangements that best meet the requirements of both parties for ensuring that the Gavi Roadmap target outcomes and the specific objectives of this tender are met. These arrangements will provide the basis upon which purchase orders will be made for specific vaccine deliveries throughout the supply period.

Please, find attached for your review RFP-DAN-2022-503423, including annexes. A copy of the Answering Sheets is also attached in word format to be completed and included in your proposal.

Kindly confirm receipt of the document and intention to bid at your earliest convenience.

Documents

RFP_DAN_2022_503423_DTwP-HepB-Hib, DTwP-HepB-Hib-IPV, DTwP vaccines to UNICEF supplied countries.pdf
RFP_DAN_2022_503423_Answering Sheets.docx
Annex A – General terms and conditions of contract for goods.pdf
Annex B – UNICEF guidelines for vaccine barcode specifications.pdf